# Evaluating Feasibility of the YATAC Programme

> **NCT06807216** · NA · COMPLETED · sponsor: **Defactum, Central Denmark Region** · enrollment: 35 (actual)

## Conditions studied

- Cancer

## Interventions

- **BEHAVIORAL:** YATAC

## Key facts

- **NCT ID:** NCT06807216
- **Lead sponsor:** Defactum, Central Denmark Region
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-04-05
- **Primary completion:** 2026-02-28
- **Final completion:** 2026-02-28
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2026-03-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06807216

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06807216, "Evaluating Feasibility of the YATAC Programme". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06807216. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*